{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:13:44Z","timestamp":1792088024276,"version":"4.4.0"},"reference-count":252,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic obstructive pulmonary disease (COPD) is a widespread disease associated with high rates of disability and mortality. COPD is characterized by chronic inflammation in the bronchi as well as systemic inflammation, which contributes significantly to the clinically heterogeneous course of the disease. Lipid metabolism disorders are common in COPD, being a part of its pathogenesis. High-density lipoproteins (HDLs) are not only involved in lipid metabolism, but are also part of the organism\u2019s immune and antioxidant defense. In addition, HDL is a versatile transport system for endogenous regulatory agents and is also involved in the removal of exogenous substances such as lipopolysaccharide. These functions, as well as information about lipoprotein metabolism disorders in COPD, allow a broader assessment of their role in the pathogenesis of heterogeneous and comorbid course of the disease.<\/jats:p>","DOI":"10.3390\/ijms23158128","type":"journal-article","created":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:49:02Z","timestamp":1658702942000},"page":"8128","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["High-Density Lipoproteins: A Role in Inflammation in COPD"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-2692","authenticated-orcid":false,"given":"Stanislav","family":"Kotlyarov","sequence":"first","affiliation":[{"name":"Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1900610","DOI":"10.1183\/13993003.00610-2019","article-title":"Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps","volume":"54","author":"Blanco","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","first-page":"455","article-title":"Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia","volume":"11","author":"Madsen","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2147\/COPD.S242914","article-title":"Reducing the Number of Hospitalization Days for COPD: Setting up a Transmural-Care Pathway","volume":"15","author":"Westbroek","year":"2020","journal-title":"Int. J. Chronic Obstruct. Pulm. Dis."},{"key":"ref_5","unstructured":"(2022, July 20). Chronic Obstructive Pulmonary Disease (COPD). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)."},{"key":"ref_6","first-page":"00253","article-title":"Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: A pooled analysis of individual patient data","volume":"6","author":"Ancochea","year":"2020","journal-title":"ERJ Open Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of airflow limitation in chronic obstructive pulmonary disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet"},{"key":"ref_8","unstructured":"(2022, July 20). Global Strategy for Prevention, Diagnosis and Management of COPD: 2022 Report. Available online: https:\/\/goldcopd.org\/2022-gold-reports-2\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","article-title":"Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline","volume":"18","author":"Marciniuk","year":"2011","journal-title":"Can. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rmed.2017.11.018","article-title":"Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study","volume":"134","author":"Miravitlles","year":"2018","journal-title":"Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/COPD.S295885","article-title":"Physical Frailty in COPD Patients with Chronic Respiratory Failure","volume":"16","author":"Gephine","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1164\/ajrccm.158.2.9711023","article-title":"Peripheral muscle weakness in patients with chronic obstructive pulmonary disease","volume":"158","author":"Bernard","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ijerph6010209","article-title":"Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century","volume":"6","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1183\/09031936.06.00074806","article-title":"Smoking and COPD: What really are the risks?","volume":"28","author":"Marsh","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Franciosi, L., Postma, D.S., van den Berge, M., Govorukhina, N., Horvatovich, P.L., Fusetti, F., Poolman, B., Lodewijk, M.E., Timens, W., and Bischoff, R. (2014). Susceptibility to COPD: Differential proteomic profiling after acute smoking. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102037"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1038\/s41598-019-49598-9","article-title":"Longitudinal decline in lung function: A community-based cohort study in Korea","volume":"9","author":"Leem","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Safitri, W., Martini, S., Artanti, K.D., and Li, C.-Y. (2021). Smoking from a Younger Age Is the Dominant Factor in the Incidence of Chronic Obstructive Pulmonary Disease: Case-Control Study. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18116047"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chen, H., Liu, X., Gao, X., Lv, Y., Zhou, L., Shi, J., Wei, W., Huang, J., Deng, L., and Wang, Z. (2021). Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0261692"},{"key":"ref_19","first-page":"E31","article-title":"Air pollution and chronic airway diseases: What should people know and do?","volume":"8","author":"Jiang","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_20","first-page":"260","article-title":"Air pollution and chronic obstructive pulmonary disease","volume":"6","author":"Duan","year":"2020","journal-title":"Chronic Dis. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S1415-47572009005000107","article-title":"Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)","volume":"33","author":"Denden","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"ref_22","first-page":"S167","article-title":"Airway inflammation in chronic obstructive pulmonary disease","volume":"6","author":"Angelis","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sutherland, E.R., and Martin, R.J. (2003). Airway inflammation in chronic obstructive pulmonary disease: Comparisons with asthma. J. Allergy Clin. Immunol., 112.","DOI":"10.1016\/S0091-6749(03)02011-6"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kotlyarov, S. (2022). Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020985"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fimmu.2014.00435","article-title":"Role of alveolar macrophages in chronic obstructive pulmonary disease","volume":"5","author":"Vlahos","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.12688\/f1000research.18411.1","article-title":"Understanding the role of neutrophils in chronic inflammatory airway disease","volume":"8","author":"Jasper","year":"2019","journal-title":"F1000Research"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000354173","article-title":"Innate immunity and chronic obstructive pulmonary disease: A mini-review","volume":"59","author":"Shaykhiev","year":"2013","journal-title":"Gerontology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.21037\/atm.2017.04.20","article-title":"Microbiome in chronic obstructive pulmonary disease","volume":"5","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/thoraxjnl-2019-214457","article-title":"Association between COPD exacerbations and lung function decline during maintenance therapy","volume":"75","author":"Kerkhof","year":"2020","journal-title":"Thorax"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2006.10.012","article-title":"Exacerbations and lung function decline in COPD: New insights in current and ex-smokers","volume":"101","author":"Makris","year":"2007","journal-title":"Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1378\/chest.07-1342","article-title":"Increased systemic inflammation is a risk factor for COPD exacerbations","volume":"133","author":"Groenewegen","year":"2008","journal-title":"Chest"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1183\/09031936.03.00004603a","article-title":"Systemic inflammation in chronic obstructive pulmonary disease","volume":"22","author":"Oudijk","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/COPD.S196210","article-title":"Lipid metabolism in chronic obstructive pulmonary disease","volume":"14","author":"Chen","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kotlyarov, S., and Kotlyarova, A. (2021). The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136711"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/2230-8210.139212","article-title":"Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat","volume":"18","author":"Naik","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: A contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet"},{"key":"ref_39","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., and Kalra, S. (2000). The Role of Lipids and Lipoproteins in Atherosclerosis. Endotext, MDText.com, Inc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","article-title":"Lipoproteins and lipids in cardiovascular disease: From mechanistic insights to therapeutic targeting","volume":"159","author":"Soppert","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2020.12.013","article-title":"New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?","volume":"319","author":"Atar","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3889\/oamjms.2016.060","article-title":"The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease","volume":"4","author":"Stojkovikj","year":"2016","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_44","first-page":"PA1204","article-title":"HDL serum levels are significantly lower in patients with COPD than in never-smokers","volume":"50","author":"Jungck","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5152\/TurkThoracJ.2017.17043","article-title":"Association between the Serum Metabolic Profile and Lung Function in Chronic Obstructive Pulmonary Disease","volume":"19","author":"Rafie","year":"2018","journal-title":"Turk. Thorac. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1183\/09031936.00147612","article-title":"APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema","volume":"43","author":"Burkart","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12872-021-02225-w","article-title":"Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: A study of the National Health and Nutrition Examination Survey database","volume":"21","author":"Shi","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/COPD.S27480","article-title":"Lung function decline in COPD","volume":"7","author":"Tantucci","year":"2012","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1164\/rccm.201911-2115OC","article-title":"Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality","volume":"202","author":"Marott","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","first-page":"OA2001","article-title":"LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL-C) and longitudinal lung function in six United States (US) cohorts","volume":"48","author":"Oelsner","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Park, J.H., Mun, S., Choi, D.P., Lee, J.Y., and Kim, H.C. (2017). Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: The JS high school study. BMC Pulm. Med., 17.","DOI":"10.1186\/s12890-017-0548-6"},{"key":"ref_52","first-page":"175","article-title":"Effect of the components of the metabolic syndrome on pulmonary function. The unexpected role of high-density lipoprotein cholesterol","volume":"86","year":"2018","journal-title":"Cir. Cir."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.rmed.2011.10.003","article-title":"Impact of lung transplantation on serum lipids in COPD","volume":"105","author":"Reed","year":"2011","journal-title":"Respir. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.healun.2010.12.010","article-title":"Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol","volume":"30","author":"Reed","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.2147\/COPD.S276372","article-title":"The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD","volume":"15","author":"Huang","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12944-016-0228-1","article-title":"High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcma.2015.08.004","article-title":"Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease","volume":"78","author":"Can","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12944-018-0904-4","article-title":"Association between chronic obstructive pulmonary disease and serum lipid levels: A meta-analysis","volume":"17","author":"Xuan","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Burkart, K.M., Ahmed, F.S., Watson, K., Hoffman, E.A., Burke, G.L., and Barr, R.G. (2010). Association between high density lipoproteins (hdl) cholesterol and ct percent emphysema. The mesa lung study. B37. Chronic Obstructive Pulmonary Disease Pathogenesis I, American Thoracic Society.","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A2878"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/thx.2008.097543","article-title":"Body mass index in male patients with COPD: Correlation with low attenuation areas on CT","volume":"64","author":"Ogawa","year":"2009","journal-title":"Thorax"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.200405-651OC","article-title":"Early emphysema in patients with anorexia nervosa","volume":"170","author":"Coxson","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.resinv.2015.05.005","article-title":"The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries","volume":"53","author":"Takahashi","year":"2015","journal-title":"Respir. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"170103","DOI":"10.1183\/16000617.0103-2017","article-title":"Exacerbations of COPD","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_64","first-page":"PA615","article-title":"LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population","volume":"46","author":"Oelsner","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: Two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Olmos, L., Alberquilla, \u00c1., Ayala, V., Garc\u00eda-Sagredo, P., Morales, L., Carmona, M., de Tena-D\u00e1vila, M.J., Pascual, M., Mu\u00f1oz, A., and Salvador, C.H. (2013). Comorbidity in patients with chronic obstructive pulmonary disease in family practice: A cross sectional study. BMC Fam. Pract., 14.","DOI":"10.1186\/1471-2296-14-11"},{"key":"ref_67","first-page":"101","article-title":"Understanding COPD: A vision on phenotypes, comorbidities and treatment approach","volume":"22","author":"Fragoso","year":"2016","journal-title":"Rev. Port. Pneumol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"00086","DOI":"10.1183\/23120541.00086-2018","article-title":"COPD is associated with an increased risk of peripheral artery disease and mortality","volume":"4","author":"Terzikhan","year":"2018","journal-title":"ERJ Open Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.21037\/jtd.2020.03.60","article-title":"Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients","volume":"12","author":"Aisanov","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Dixmier","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.10-2644","article-title":"Increased adverse events after percutaneous coronary intervention in patients with COPD: Insights from the National Heart, Lung, and Blood Institute dynamic registry","volume":"140","author":"Enriquez","year":"2011","journal-title":"Chest"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/crj.13253","article-title":"Metabolic syndrome prevalence in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease: Relationship with systemic inflammation","volume":"14","author":"Zhou","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.sleep.2016.02.012","article-title":"Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome","volume":"30","author":"Kuklisova","year":"2017","journal-title":"Sleep Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3949\/ccjm.83a.14104","article-title":"The intersection of obstructive lung disease and sleep apnea","volume":"83","author":"Khatri","year":"2016","journal-title":"Cleve. Clin. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/COPD.S228497","article-title":"Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs","volume":"14","author":"Choi","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.4103\/jfmpc.jfmpc_1640_21","article-title":"Prevalence of metabolic syndrome in chronic obstructive pulmonary disease and its correlation with severity of disease","volume":"11","author":"Sahoo","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1262-3636(07)70031-9","article-title":"The metabolic syndrome in smokers. The D.E.S.I.R. study","volume":"29","author":"Vol","year":"2003","journal-title":"Diabetes Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12931-019-1209-5","article-title":"BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: A meta-analysis of clinical trials","volume":"20","author":"Sun","year":"2019","journal-title":"Respir. Res."},{"key":"ref_79","first-page":"229","article-title":"Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index","volume":"1","author":"Divo","year":"2014","journal-title":"Chronic Obstr. Pulm. Dis. J. COPD Found."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/15412555.2019.1589443","article-title":"Low Body Mass Index Is Associated with Higher Odds of COPD and Lower Lung Function in Low- and Middle-Income Countries","volume":"16","author":"Grigsby","year":"2019","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1159\/000511022","article-title":"Impact of Body Mass Index Change on the Prognosis of Chronic Obstructive Pulmonary Disease","volume":"99","author":"Kim","year":"2020","journal-title":"Respiration"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41598-020-79860-4","article-title":"Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: The JACC study","volume":"11","author":"Wada","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/joim.12949","article-title":"The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality","volume":"286","author":"Park","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e4225","DOI":"10.1097\/MD.0000000000004225","article-title":"Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis","volume":"95","author":"Guo","year":"2016","journal-title":"Medicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1513\/AnnalsATS.201711-901ED","article-title":"The \u201cObesity Paradox\u201d in Chronic Obstructive Pulmonary Disease: Can It Be Resolved?","volume":"15","author":"Iyer","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/aje\/kwz185","article-title":"Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States","volume":"188","author":"Wu","year":"2019","journal-title":"Am. J. Epidemiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"A73","DOI":"10.1136\/thx.2010.150953.14","article-title":"S163\u2005The \u2018Obesity Paradox\u2019 in chronic obstructive pulmonary disease","volume":"65","author":"Collins","year":"2010","journal-title":"Thorax"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jvs.2017.04.056","article-title":"Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease","volume":"66","author":"Orbe","year":"2017","journal-title":"J. Vasc. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","article-title":"Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease","volume":"46","author":"Kanbay","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00059-015-4393-1","article-title":"Association of monocyte\/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease","volume":"41","author":"Kundi","year":"2016","journal-title":"Herz"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pjnns.2017.08.011","article-title":"Monocyte\/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients","volume":"52","author":"Bolayir","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/njcp.njcp_54_19","article-title":"Could monocyte level\/HDL cholesterol ratio predict cardiovascular diseases in patients with COPD?","volume":"23","author":"Yakar","year":"2020","journal-title":"Niger. J. Clin. Pract."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12944-022-01638-6","article-title":"Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: A nationwide cohort study in the United States","volume":"21","author":"Jiang","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0003319717704748","article-title":"Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Beh\u00e7et Disease","volume":"69","author":"Acikgoz","year":"2018","journal-title":"Angiology"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Y\u0131lmaz, M., and Kayan\u00e7i\u00e7ek, H. (2018). A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with Smoking. J. Clin. Med., 7.","DOI":"10.3390\/jcm7040076"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/17476348.2013.838018","article-title":"Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities","volume":"7","author":"Young","year":"2013","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1183\/09059180.00005309","article-title":"Pharmacological actions of statins: Potential utility in COPD","volume":"18","author":"Young","year":"2009","journal-title":"Eur. Respir. Rev."},{"key":"ref_98","first-page":"Cd011959","article-title":"Statins versus placebo for people with chronic obstructive pulmonary disease","volume":"7","author":"Walsh","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejcdt.2013.01.006","article-title":"Anti inflammatory effects of statin in COPD","volume":"62","author":"Rezk","year":"2013","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/COPD.S296472","article-title":"Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality\u2014The STATUETTE Cohort Study","volume":"16","author":"Kallemose","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chest.2017.02.002","article-title":"The impact of statin drug use on all-cause mortality in patients with COPD: A population-based cohort study","volume":"152","author":"Raymakers","year":"2017","journal-title":"Chest"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/srep16461","article-title":"The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: A systematic review and meta-analysis of observational research","volume":"5","author":"Cao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/thoraxjnl-2014-205795","article-title":"Statin use and exacerbations in individuals with chronic obstructive pulmonary disease","volume":"70","author":"Ingebrigtsen","year":"2015","journal-title":"Thorax"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2147\/IJGM.S309647","article-title":"No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years","volume":"14","author":"Yayan","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e050757","DOI":"10.1136\/bmjopen-2021-050757","article-title":"Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: A retrospective cohort study in the Clinical Practice Research Datalink","volume":"11","author":"Smith","year":"2021","journal-title":"BMJ Open"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2019.02.007","article-title":"Associations between statins and coronary artery disease and stroke risks in patients with asthma\u2013chronic obstructive pulmonary disease overlap syndrome: A time-dependent regression study","volume":"283","author":"Yeh","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-012-0235-2","article-title":"High-density lipoprotein and atherosclerosis: The role of antioxidant activity","volume":"14","author":"Bandeali","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1038\/s41598-017-10879-w","article-title":"Targeting cholesterol homeostasis in lung diseases","volume":"7","author":"Sallese","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and lipid metabolism","volume":"330","author":"Remmerie","year":"2018","journal-title":"Cell. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2010.02.017","article-title":"The molecular basis of pulmonary alveolar proteinosis","volume":"135","author":"Carey","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_114","first-page":"L634","article-title":"Lipoprotein-stimulated surfactant secretion in alveolar type II cells: Mediation by heterotrimeric G proteins","volume":"273","author":"Pian","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0891-5849(99)00139-2","article-title":"HDL is the major source of vitamin E for type II pneumocytes","volume":"27","author":"Kolleck","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1348-0421.2009.00203.x","article-title":"Plasma lipoproteins are important components of the immune system","volume":"54","author":"Han","year":"2010","journal-title":"Microbiol. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"684903","DOI":"10.1155\/2013\/684903","article-title":"High-density lipoproteins and the immune system","volume":"2013","author":"Kaji","year":"2013","journal-title":"J. Lipids"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1194\/jlr.R800063-JLR200","article-title":"Regulation of macrophage function in inflammation and atherosclerosis","volume":"50","author":"Shibata","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/bi00337a028","article-title":"Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages","volume":"24","author":"Zannis","year":"1985","journal-title":"Biochemistry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: Progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"von Eckardstein, A., and Kardassis, D. (2015). HDL Biogenesis, Remodeling, and Catabolism. High Density Lipoproteins: From Biological Understanding to Clinical Exploitation, Springer International Publishing.","DOI":"10.1007\/978-3-319-09665-0"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2011.00183","article-title":"The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids","volume":"18","author":"Zhao","year":"2012","journal-title":"Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmet.2010.04.006","article-title":"Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation","volume":"11","author":"Smoak","year":"2010","journal-title":"Cell Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI200316808","article-title":"A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I","volume":"111","author":"Wang","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1194\/jlr.M085332","article-title":"A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL","volume":"59","author":"Cooke","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/17584299.4.1.113","article-title":"Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices","volume":"4","author":"Bhat","year":"2009","journal-title":"Clin. Lipidol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"A541","DOI":"10.1161\/atvb.36.suppl_1.541","article-title":"Abstract 541: The Molecular Interaction of Apolipoprotein A-I Containing High Density Lipoproteins with Lecithin: Cholesterol Acyl Transferase","volume":"36","author":"Cooke","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1194\/jlr.M082685","article-title":"Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides","volume":"59","author":"Casteleijn","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1165\/rcmb.2016-0060TR","article-title":"Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease","volume":"55","author":"Yao","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fphar.2016.00323","article-title":"High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease","volume":"7","author":"Gordon","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1194\/jlr.M004549","article-title":"Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung","volume":"51","author":"Wang","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/JOE-08-0238","article-title":"Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids","volume":"200","author":"Provost","year":"2009","journal-title":"J. Endocrinol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1165\/rcmb.2014-0305OC","article-title":"Attenuation of Cigarette Smoke-Induced Emphysema in Mice by Apolipoprotein A-1 Overexpression","volume":"54","author":"Kim","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1741-7015-11-195","article-title":"Associations between smoking, components of metabolic syndrome and lipoprotein particle size","volume":"11","author":"Slagter","year":"2013","journal-title":"BMC Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1700681","DOI":"10.1183\/13993003.00681-2017","article-title":"Interplay between cigarette smoking and pulmonary reverse lipid transport","volume":"50","author":"Jubinville","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/rccm.201411-1990OC","article-title":"Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma","volume":"191","author":"Barochia","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"134","DOI":"10.23888\/PAVLOVJ2021291134-146","article-title":"Role of lipid metabolism and systemic inflammation in the development of atherosclerosis in animal models","volume":"29","author":"Kotlyarov","year":"2021","journal-title":"IP Pavlov. Russ. Med. Biol. Her."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/iai.60.2.596-601.1992","article-title":"In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins","volume":"60","author":"Emancipator","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/abbs\/36.6.419","article-title":"Role of apolipoprotein A-I in protecting against endotoxin toxicity","volume":"36","author":"Ma","year":"2004","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cyto.2008.04.002","article-title":"Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid","volume":"43","author":"Jiao","year":"2008","journal-title":"Cytokine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1753425910370709","article-title":"Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect","volume":"17","author":"Henning","year":"2011","journal-title":"Innate Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00109-010-0690-6","article-title":"Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation","volume":"89","author":"Spillmann","year":"2011","journal-title":"J. Mol. Med."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sharifov, O.F., Xu, X., Gaggar, A., Grizzle, W.E., Mishra, V.K., Honavar, J., Litovsky, S.H., Palgunachari, M.N., White, C.R., and Anantharamaiah, G.M. (2013). Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064486"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1046\/j.1432-1033.2002.03333.x","article-title":"Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins","volume":"269","author":"Brandenburg","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Georgila, K., Vyrla, D., and Drakos, E. (2019). Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers, 11.","DOI":"10.3390\/cancers11081097"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.180.3.1025","article-title":"Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS","volume":"180","author":"Wurfel","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fsi.2014.09.020","article-title":"Characterization, expression and antibacterial properties of apolipoproteins A from carp (Cyprinus carpio L.) seminal plasma","volume":"41","author":"Dietrich","year":"2014","journal-title":"Fish Shellfish. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.fsi.2015.05.048","article-title":"Expression of apolipoprotein A-I and A-II in rainbow trout reproductive tract and their possible role in antibacterial defence","volume":"45","author":"Dietrich","year":"2015","journal-title":"Fish Shellfish. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00253-019-10204-7","article-title":"Structural-functional characterization of recombinant Apolipoprotein A-I fromLabeo rohitademonstrates heat-resistant antimicrobial activity","volume":"104","author":"Karan","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"110329","DOI":"10.1016\/j.cbpb.2019.110329","article-title":"Identification, expression analysis, and antibacterial activity of Apolipoprotein A-I from amphioxus (Branchiostoma belcheri)","volume":"238","author":"Wang","year":"2019","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"38211","DOI":"10.1074\/jbc.M111.249482","article-title":"Apolipoprotein A-I Exerts Bactericidal Activity against Yersinia enterocolitica Serotype O:3*","volume":"286","author":"Metso","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-3542(99)00032-7","article-title":"Lipoproteins account for part of the broad non-specific antiviral activity of human serum","volume":"42","author":"Singh","year":"1999","journal-title":"Antivir. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1194\/jlr.M065797","article-title":"Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I\/ABCA1 interaction in macrophages","volume":"57","author":"Tang","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Cheng, A.M., Handa, P., Tateya, S., Schwartz, J., Tang, C., Mitra, P., Oram, J.F., Chait, A., and Kim, F. (2012). Apolipoprotein A-I attenuates palmitate-mediated NF-\u03baB activation by reducing Toll-like receptor-4 recruitment into lipid rafts. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033917"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.atherosclerosis.2016.03.008","article-title":"Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation","volume":"248","author":"Zhang","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/ATVBAHA.120.315037","article-title":"Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein)","volume":"40","author":"Low","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1253\/circj.CJ-17-0877","article-title":"Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages","volume":"82","author":"Zhang","year":"2018","journal-title":"Circ. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e120519","DOI":"10.1172\/jci.insight.120519","article-title":"AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation","volume":"3","author":"Choi","year":"2018","journal-title":"JCI Insight"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11745-002-0981-4","article-title":"Apolipoproteins A-I and A-II downregulate neutrophil functions","volume":"37","author":"Furlaneto","year":"2002","journal-title":"Lipids"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Meilhac, O., Tanaka, S., and Couret, D. (2020). High-Density Lipoproteins Are Bug Scavengers. Biomolecules, 10.","DOI":"10.3390\/biom10040598"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Jacobo-Albavera, L., Dom\u00ednguez-P\u00e9rez, M., Medina-Leyte, D.J., Gonz\u00e1lez-Garrido, A., and Villarreal-Molina, T. (2021). The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041593"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12931-017-0526-9","article-title":"Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation","volume":"18","author":"Chai","year":"2017","journal-title":"Respir. Res."},{"key":"ref_166","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Ranalletta","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1742-4658.2011.08170.x","article-title":"Function and regulation of ABCA1\u2014Membrane meso-domain organization and reorganization","volume":"278","author":"Nagao","year":"2011","journal-title":"FEBS J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"21763","DOI":"10.1074\/jbc.M501759200","article-title":"Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1073\/pnas.0510345103","article-title":"TNF\u03b1 induces ABCA1 through NF-\u03baB in macrophages and in phagocytes ingesting apoptotic cells","volume":"103","author":"Li","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1194\/jlr.M600127-JLR200","article-title":"ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis","volume":"47","author":"Iwamoto","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1074\/jbc.M309888200","article-title":"Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density Lipoprotein*","volume":"279","author":"Ikeda","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1194\/jlr.M006049","article-title":"Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7 [S]","volume":"51","author":"Tanaka","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"L980","DOI":"10.1152\/ajplung.00234.2005","article-title":"Pulmonary abnormalities due to ABCA1 deficiency in mice","volume":"289","author":"Bates","year":"2005","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.97.8.4245","article-title":"High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1","volume":"97","author":"McNeish","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Kotlyarov, S., and Kotlyarova, A. (2021). Bioinformatic Analysis of ABCA1 Gene Expression in Smoking and Chronic Obstructive Pulmonary Disease. Membranes, 11.","DOI":"10.3390\/membranes11090674"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12944-017-0482-x","article-title":"High density lipoprotein promoting proliferation and migration of type II alveolar epithelial cells during inflammation state","volume":"16","author":"Yu","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR signaling couples sterol metabolism to proliferation in the acquired immune response","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.107.156935","article-title":"Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels","volume":"28","author":"Out","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1194\/jlr.M600218-JLR200","article-title":"ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL","volume":"47","author":"Vaughan","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.mol.0000226116.35555.eb","article-title":"Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages","volume":"17","author":"Jessup","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-Binding cassette cholesterol transporters and cardiovascular disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.bbamem.2008.06.010","article-title":"Functional ABCG1 expression induces apoptosis in macrophages and other cell types","volume":"1778","author":"Seres","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.180.6.4273","article-title":"A critical role for ABCG1 in macrophage inflammation and lung homeostasis","volume":"180","author":"Wojcik","year":"2008","journal-title":"J. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.4049\/jimmunol.1400606","article-title":"ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis","volume":"193","author":"Baldan","year":"2014","journal-title":"J. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.4049\/jimmunol.180.5.3560","article-title":"Loss of ABCG1 Results in Chronic Pulmonary Inflammation","volume":"180","author":"Gomes","year":"2008","journal-title":"J. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1183\/09031936.00121611","article-title":"Matrix metalloproteinases in COPD","volume":"39","author":"Churg","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/15412555.2016.1249790","article-title":"MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD","volume":"14","author":"Sng","year":"2017","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1164\/rccm.200910-1580OC","article-title":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung","volume":"182","author":"Draper","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chemphyslip.2016.05.003","article-title":"The role of cholesterol in membrane fusion","volume":"199","author":"Yang","year":"2016","journal-title":"Chem. Phys. Lipids"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0854.2004.0170.x","article-title":"Transmembrane Asymmetry and Lateral Domains in Biological Membranes","volume":"5","author":"Devaux","year":"2004","journal-title":"Traffic"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pro.2385","article-title":"Cholesterol as a co-solvent and a ligand for membrane proteins","volume":"23","author":"Song","year":"2014","journal-title":"Protein Sci."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Rosenhouse-Dantsker, A., and Bukiya, A.N. (2019). Cholesterol-Recognition Motifs in Membrane Proteins. Direct Mechanisms in Cholesterol Modulation of Protein Function, Springer International Publishing.","DOI":"10.1007\/978-3-030-14265-0"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2013.00031","article-title":"How cholesterol interacts with membrane proteins: An exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains","volume":"4","author":"Fantini","year":"2013","journal-title":"Front. Physiol."},{"key":"ref_196","first-page":"956","article-title":"Cholesterol sensing by the ABCG1 lipid transporter: Requirement of a CRAC motif in the final transmembrane domain","volume":"1851","author":"Sharpe","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2147\/COPD.S249131","article-title":"The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease","volume":"15","author":"Sidletskaya","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/09680519010070040901","article-title":"Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: Genetic and evolutionary studies","volume":"7","author":"Beutler","year":"2001","journal-title":"J. Endotoxin Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"27384","DOI":"10.1074\/jbc.M109.044065","article-title":"Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner","volume":"284","author":"Wong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-9255-6-12","article-title":"Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages","volume":"6","author":"Sarir","year":"2009","journal-title":"J. Inflamm."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1172\/JCI28139","article-title":"Toll-like receptor 4 deficiency causes pulmonary emphysema","volume":"116","author":"Zhang","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","article-title":"Role of lipid microdomains in TLR-mediated signalling","volume":"1848","author":"Ruysschaert","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/ATVBAHA.108.168690","article-title":"High-density lipoprotein reduces the human monocyte inflammatory response","volume":"28","author":"Murphy","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12931-020-01515-9","article-title":"Regulation of ATP binding cassette transporter A1 (ABCA1) expression: Cholesterol-dependent and\u2014Independent signaling pathways with relevance to inflammatory lung disease","volume":"21","author":"He","year":"2020","journal-title":"Respir. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"fj201701381","DOI":"10.1096\/fj.201701381","article-title":"A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure","volume":"32","author":"Sonett","year":"2018","journal-title":"FASEB J."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphs.2021.11.005","article-title":"ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis","volume":"148","author":"Matsuo","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tem.2020.01.003","article-title":"A Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis?","volume":"31","author":"Blauw","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tem.2012.02.001","article-title":"Crosstalk between reverse cholesterol transport and innate immunity","volume":"23","author":"Azzam","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Topchiy, E., Cirstea, M., Kong, H.J., Boyd, J.H., Wang, Y., Russell, J.A., and Walley, K.R. (2016). Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160326"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1074\/jbc.REV120.015254","article-title":"Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery","volume":"295","author":"Munford","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1194\/jlr.R082735","article-title":"Cholesteryl ester transfer protein and its inhibitors","volume":"59","author":"Shrestha","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","article-title":"Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis","volume":"199","author":"Trinder","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/SHK.0b013e31816e30fd","article-title":"Human cholesteryl ester transfer protein expression enhances the mouse survival rate in an experimental systemic inflammation model: A novel role for CETP","volume":"30","author":"Cazita","year":"2008","journal-title":"Shock"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"684076","DOI":"10.3389\/fimmu.2021.684076","article-title":"Cholesterol-Ester Transfer Protein Alters M1 and M2 Macrophage Polarization and Worsens Experimental Elastase-Induced Pulmonary Emphysema","volume":"12","author":"Santana","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"40502","DOI":"10.1074\/jbc.M112.413245","article-title":"ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","article-title":"Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins","volume":"263","author":"Tall","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MOL.0000000000000352","article-title":"Clinical trials with cholesteryl ester transfer protein inhibitors","volume":"27","author":"Duong","year":"2016","journal-title":"Curr. Opin. Lipidol"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1194\/jlr.M600332-JLR200","article-title":"Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits","volume":"48","author":"Morehouse","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-Density Lipoprotein Suppresses the Type I Interferon Response, a Family of Potent Antiviral Immunoregulators, in Macrophages Challenged With Lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"Labzin","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"BBA Clin."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11883-006-0038-4","article-title":"High-density lipoprotein: Is it always atheroprotective?","volume":"8","author":"Ansell","year":"2006","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","article-title":"High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-\u03baB\/STAT1-IRF1 Signaling","volume":"25","author":"Theodorou","year":"2017","journal-title":"Cell Metab."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1161\/ATVBAHA.119.313253","article-title":"Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques","volume":"39","author":"Fotakis","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Hama","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","article-title":"The role of dysfunctional HDL in atherosclerosis","volume":"50","author":"Navab","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"274629","DOI":"10.1155\/2011\/274629","article-title":"Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response","volume":"2011","author":"G","year":"2011","journal-title":"Cholesterol"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1172\/JCI83475","article-title":"Serum amyloid A impairs the antiinflammatory properties of HDL","volume":"126","author":"Han","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2147\/COPD.S266844","article-title":"Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype","volume":"15","author":"Zhao","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.200705-678OC","article-title":"Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease","volume":"177","author":"Bozinovski","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOL.0b013e328350a425","article-title":"Lipid-based carriers of microRNAs and intercellular communication","volume":"23","author":"Vickers","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fmed.2020.00196","article-title":"miR-223: A Key Regulator in the Innate Immune Response in Asthma and COPD","volume":"7","author":"Roffel","year":"2020","journal-title":"Front. Med."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/joim.12099","article-title":"miR-223: Infection, inflammation and cancer","volume":"274","author":"Haneklaus","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nature06607","article-title":"Regulation of progenitor cell proliferation and granulocyte function by microRNA-223","volume":"451","author":"Johnnidis","year":"2008","journal-title":"Nature"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thoraxjnl-2011-200089","article-title":"Gene expression networks in COPD: microRNA and mRNA regulation","volume":"67","author":"Ezzie","year":"2012","journal-title":"Thorax"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom5031266","article-title":"NF-kappaB Signaling in Chronic Inflammatory Airway Disease","volume":"5","author":"Schuliga","year":"2015","journal-title":"Biomolecules"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.celrep.2018.01.058","article-title":"MicroRNA-223 Suppresses the Canonical NF-\u03baB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation","volume":"22","author":"Zhou","year":"2018","journal-title":"Cell Rep."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12931-020-01374-4","article-title":"MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00109-016-1388-1","article-title":"MicroRNA-223 controls the expression of histone deacetylase 2: A novel axis in COPD","volume":"94","author":"Leuenberger","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"Tabet","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"da Costa, C.H., Noronha Filho, A.J., Marques e Silva, R.M.F., da Cruz, T.F., de Oliveira Monteiro, V., Pio, M., and Rufino, R.L. (2019). Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: Is systematic screening necessary?. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-018-4043-9"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1165\/rcmb.2013-0103OC","article-title":"High-Density Lipoproteins Potentiate \u03b11-Antitrypsin Therapy in Elastase-Induced Pulmonary Emphysema","volume":"51","author":"Moreno","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1161\/atvb.36.suppl_1.29","article-title":"Abstract 29: Alpha-1-antitrypsin Protects High Density Lipoprotein From Functional Inactivation by Elastase","volume":"36","author":"Gordon","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"104528","DOI":"10.1016\/j.cellimm.2022.104528","article-title":"The lipid ties of \u03b11-antitrypsin: Structural and functional aspects","volume":"375","author":"Segal","year":"2022","journal-title":"Cell Immunol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"34116","DOI":"10.1074\/jbc.274.48.34116","article-title":"Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface","volume":"274","author":"Kitchens","year":"1999","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8128\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:28Z","timestamp":1760140528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":252,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158128"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158128","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]}}}